Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 179 Records) |
| Query Trace: Primary Myelofibrosis and JAK2[original query] |
|---|
| [Clinical impact of gene mutations on myeloproliferative neoplasms in Japan]. [Rinsho ketsueki] The Japanese journal of clinical hematology 2021 9 62 (8): 1060-1069. Morishita So |
| The impact of JAK2V617F mutation on Philadelphia-negative myeloproliferative neoplasms. Turkish journal of medical sciences 2021 9 52 (1): 150-165. ?ahin Ezgi, Yönal-Hindilerden ?pek, Hindilerden Fehmi, Aday Aynur, Nalçac? Meli |
| MAPK14 over-expression is a transcriptomic feature of polycythemia vera and correlates with adverse clinical outcomes. Journal of translational medicine 2021 6 19 (1): 233. Guo Chao, Gao Ya-Yue, Ju Qian-Qian, Wang Min, Zhang Chun-Xia, Gong Ming, Li Zhen-Li |
| JAK2, CALR, and MPL Mutation Profiles in BCR-ABL Negative Myeloproliferative Neoplasms, a Referral Center Experience in the Middle East. Iranian journal of pathology 2021 5 16 (2): 190-194. Safavi Moeinadin, Monabati Ahmad, Safaei Akbar, Mirtalebi Maryam Sadat, Faghih Masoum |
| High Risk Janus Kinase 2 V617F Allele Burden in a Seven-Year Cohort of Patients with Myeloproliferative Neoplasms. Clinical laboratory 2021 11 67 (11): . Chatambudza Moses, Skhosana Lindiwe, Ketseoglou Irene, Wiggill Trac |
| JAK2 p.(V617F) mutation in Tunisian myeloproliferative neoplasms and its genotype-phenotype correlation. The Pan African medical journal 2021 39 194. Sassi Hela, Menif Samia, Ammar Safa Ben, Farrah Ahlem, Othmen Hend Ben Hadj, Amouri Hassi |
| JAK2 rs10974944 is associated with both V617F-positive and negative myeloproliferative neoplasms in a Vietnamese population: A potential genetic marker. Molecular genetics & genomic medicine 2022 Aug e2044. Ngoc Nguyen Thy, Hau Bui Bich, Vuong Nguyen Ba, Xuan Nguyen T |
| The differences of hemogram, myelogram, and driver gene mutations in classic myeloproliferative neoplasms. Blood cells, molecules & diseases 2022 8 97 102698. Wang Jin, Zhang Jin, Huang Jinjin, Mei Yu, Hong Zhen |
| Development of a Real-Time qPCR Assay for Detection of Common MPL Mutations in Myeloproliferative Neoplasms (MPNS). Applied biochemistry and biotechnology 2022 7 194 (12): 5907-5917. Ullah Naeem, Khan Sadiq Noor, Umair Muhammad, Khan Aamir Ali, Liu Xinhui, Khattak Aamer Ali, Yousafzai Yasar Mehmo |
| Targeted sequencing of candidate gene regions for myelofibrosis in dogs. Journal of veterinary internal medicine 2022 7 36 (4): 1237-1247. Campbell Amelia G, Seelig Davis M, Beckman Joan D, Minor Katie M, Heinrich Daniel A, Friedenberg Steven G, Modiano Jaime F, Furrow E |
| TET2, DNMT3A, IDH1, and JAK2 Mutation in Myeloproliferative Neoplasms in southern Iran. International journal of organ transplantation medicine 2022 5 12 (3): 12-20. Abedi E, Ramzi M, Karimi M, Yaghobi R, Mohammadi H, Bayat E, Moghadam M, Farokhian F, Dehghani M, Golafshan H A, Haghpanah |
| Study of CALR, MPL, and c-kit Gene Mutations in Thai Patients with JAK2 V617F Negative Myeloproliferative Neoplasms. Asian Pacific journal of cancer prevention : APJCP 2022 5 23 (5): 1671-1678. Wiriyaukaradecha Kriangpol, Nimsanor Supanee, Tantirukdham Nithiphut, Tongsom Jin, Bunyoo Chakrit, Soonklang Kamonwan, Sritana Narongrit, Auewarakul Chira |
| Clonal Megakaryocyte Dysplasia with Isolated Thrombocytosis Is a Distinct Myeloproliferative Neoplasm Phenotype. Acta haematologica 2022 11 146 (1): 14-25. Barosi Giovanni, Campanelli Rita, Massa Margherita, Catarsi Paolo, Carolei Adriana, Abbà Carlotta, Villani Laura, Magrini Umberto, Gregato Giuliana, Bertolini Francesco, de Silvestri Annalisa, Gale Robert Peter, Rosti Vittor |
| Increased risk of thrombosis in JAK2 V617F-positive patients with primary myelofibrosis and interaction of the mutation with the IPSS score. Blood cancer journal 2022 11 12 (11): 156. Barbui Tiziano, Ghirardi Arianna, Carobbio Alessandra, Masciulli Arianna, Carioli Greta, Rambaldi Alessandro, Finazzi Maria Chiara, Bellini Marta, Rumi Elisa, Vanni Daniele, Borsani Oscar, Passamonti Francesco, Mora Barbara, Brociner Marco, Guglielmelli Paola, Paoli Chiara, Alvarez-Larran Alberto, Triguero Ana, Garrote Marta, Pettersson Helna, Andréasson Björn, Barosi Giovanni, Vannucchi Alessandro Mar |
| Effects of CALR-Mutant Type and Burden on the Phenotype of Myeloproliferative Neoplasms. Diagnostics (Basel, Switzerland) 2022 11 12 (11): . Kim Hyun-Young, Han Yujin, Jang Jun Ho, Jung Chul Won, Kim Sun-Hee, Kim Hee-J |
| The Clinical Impact of JAK2V617F allele burden in Philadelphia-negative Myeloproliferative Neoplasms. Turkish journal of haematology : official journal of Turkish Society of Haematology 2023 8 . ?pek Yönal-Hindilerden, Ezgi ?ahin, Fehmi Hindilerden, Aynur Da?lar-Aday, Meliha Nalça |
| Case report: Application of targeted NGS for the detection of non-canonical driver variants in MPN. Frontiers in genetics 2023 7 14 1198834. Jin Zhang, Kefeng Shen, Min Xiao, Jinjin Huang, Jin Wang, Yaqin Wang, Zhenya Ho |
| Allelic burden of Janus kinase 2 in a 6-month course of therapy for myeloproliferative neoplasms. Molecular biology reports 2023 5 . It?r ?irino?lu Demiriz, Mehmet Hanifi Kazanci, Esra Menfaatli, Davoud Jafari-Gharabaghlou, Nosratollah Zargha |
| JAK2/STAT5 Pathway Mutation Frequencies in South African BCR/ABL Negative MPN Patients. Hematology/oncology and stem cell therapy 2023 4 16 (3): 303-314. Shires Karen L, Rust Adriana J, Harryparsad Rushil, Coburn Justin A, Gopie Ruth |
| Increase in Frequency of Myeloid-Derived Suppressor Cells in the Bone Marrow of Myeloproliferative Neoplasm: Potential Implications in Myelofibrosis. Advances in experimental medicine and biology 2023 4 1408 273-290. Sun?ica Kapor, Sanja Mom?ilovi?, Slobodan Kapor, Slavko Mojsilovi?, Milica Radojkovi?, Milica Apostolovi?, Branka Filipovi?, Mirjana Goti?, Vladan ?oki?, Juan F Santiban |
| Exploration of the role of NKG2D ligands MICA and MICB in JAK2 V617F-positive myeloproliferative neoplasms. HLA 2023 4 . Ivanova Milena, Tsvetkova Gergana, Lessichkova Spaska, Gesheva Nevena, Hadjiev Evgueniy, Shivarov Veliz |
| Genetic and Clinical Characteristics of Patients with Philadelphia-Negative Myeloproliferative Neoplasm Carrying Concurrent Mutations in JAK2V617F, CALR, and MPL. Technology in cancer research & treatment 2023 2 22 15330338231154092. Wang Yan, Ran Fei, Lin Jin, Zhang Jing, Ma D |
| The Impact of JAK2 V617F, CALR, and MPL Mutations as Molecular Diagnostic Markers of Myeloproliferative Neoplasms in Kurdish Patients. A Single-center Experience. Cellular and molecular biology (Noisy-le-Grand, France) 2023 2 68 (8): 202-209. Basim Najm Maysam, Jalal Sana Dlawar, Getta Hisham Ar |
| Triple-Negative Primary Myelofibrosis: A Bone Marrow Pathology Group Study. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2023 2 36 (3): 100016. Al-Ghamdi Yahya A, Lake Jonathan, Bagg Adam, Thakral Beenu, Wang Sa A, Bueso-Ramos Carlos, Masarova Lucia, Verstovsek Srdan, Rogers Heesun J, Hsi Eric D, Gralewski Jonathon H, Chabot-Richards Devon, George Tracy I, Rets Anton, Hasserjian Robert P, Weinberg Olga K, Parilla Megan, Arber Daniel A, Padilla Osvaldo, Orazi Attilio, Tam Way |
| STAT5a and SH2B3 novel mutations display malignancy roles in a triple-negative primary myelofibrosis patient. Cancer gene therapy 2023 12 . Shubing Zhang, Jinhua Yan, Lan He, Zhiping Jiang, Hao Jia |
| JAK2, CALR, and MPL Mutation Profiles in Colombian patients with BCR-ABL Negative Myeloproliferative Neoplasms. Colombia medica (Cali, Colombia) 2023 12 54 (3): e2035353. Ana Isabel Giraldo-Rincón, Sara Naranjo Molina, Natalia Gomez-Lopera, Daniel Aguirre Acevedo, Andrea Ucroz Benavidez, Kenny Gálvez Cárdenas, Francisco Cuellar Ambrosí, Jose Domingo Torres, Sigifredo Ospina, Katherine Palacio, Lina Gaviria Jaramillo, Carlos Mario Muñeton, Gonzalo Vasquez Palac |
| Prevalence and clinicopathological features of driver gene mutations profile in BCR: ABL1 negative classical myeloproliferative neoplasm-A single-center study from North India. Indian journal of pathology & microbiology 2024 5 . Khaliqur Rahman, Seema Biswas, Akhilesh Sharma, Kusum Gupta, Dinesh Chandra, Manish K Singh, Ruchi Gupta, Ashish Mishra, Sanjeev Kumar, Anshul Gupta, Faheema Hasan, Soniya Nityanand, Rajesh Kahsy |
| Myeloproliferative Neoplasm Symptom Assessment Total Symptom Score (MPN-SAF TSS) in Chronic Myeloproliferative Neoplasms, Related with Genetic Burden, and Thrombosis. Turkish journal of haematology : official journal of Turkish Society of Haematology 2024 5 . Elif Ümit, Mehmet Baysal, Hakk? Onur K?rk?zlar, Ahmet Muzaffer Dem |
| The Association Between Janus Kinase 2 and Factor V Leiden Mutations and Thrombotic Complications in Patients With Myeloproliferative Disorders: A Study From Saudi Arabia. Cureus 2024 12 16 (11): e74401. Wafaa S Sayed, Aws Al-Bayati, Lina G Elzubair, Sherif Mohamed, Mueed Alhart |
| Molecular Profile of BCR-ABL1 Negative Myeloproliferative Neoplasm in a Moroccan Population. Asian Pacific journal of cancer prevention : APJCP 2024 11 25 (11): 4013-4025. Somda Georgina Charlène Soro, Ghita Amalou, Sara Benchikh, Adil El Hamouchi, Hicham Charoute, Mourad Oukheda, Benani Bennani Abdelouaheb, Rachid Saile, Halima Lebrazi, Sanaa Nassereddi |
- Page last reviewed:Feb 1, 2024
- Content source: